A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

BACKGROUND: Pegylated liposomal doxorubicin (PLD) is active in metastatic breast cancer. This observational study evaluated the efficacy and safety of PLD in patients treated during routine clinical practice. METHODS: Eligible patients had metastatic breast cancer and were treated with PLD according...

Descripción completa

Detalles Bibliográficos
Autores principales: Huober, Jens, Fett, Werner, Nusch, Arnd, Neise, Michael, Schmidt, Marcus, Wischnik, Arthur, Gerhardt, Steffen, Goehler, Thomas, Lück, Hans-Joachim, Rost, Andreas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806246/
https://www.ncbi.nlm.nih.gov/pubmed/20047698
http://dx.doi.org/10.1186/1471-2407-10-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806246/
https://www.ncbi.nlm.nih.gov/pubmed/20047698
http://dx.doi.org/10.1186/1471-2407-10-2

Ejemplares similares